{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:35:18Z","timestamp":1793230518279,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T00:00:00Z","timestamp":1469232000000},"content-version":"vor","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004911","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Piau\u00ed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.cbi.2015.06.037","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T14:24:48Z","timestamp":1435847088000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives"],"prefix":"10.1016","volume":"239","author":[{"given":"Patr\u00edcia Mar\u00e7al","family":"da Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcilia Pinheiro","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Andrade","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suellen Melo Tib\u00farcio","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Ver\u00edssimo","family":"de Oliveira Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gev\u00e2nio Bezerra","family":"de Oliveira Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"de Ara\u00fajo Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Vagnaldo","family":"Fechine-Jamacaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina Lima","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel Odorico","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Michel Pinheiro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2015.06.037_b0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2012.03.008","article-title":"Anti-angiogenesis therapy in cancer: current challenges and future perspectives","volume":"320","author":"Shojaei","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2015.06.037_b0010","first-page":"222","article-title":"Angiogenesis inhibitors \u2013 current strategies and future prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cbi.2015.06.037_b0015","first-page":"79","article-title":"Natural products used as candidates for angiogenesis inhibitors in cancer therapy","volume":"15","author":"Carvalho","year":"2011","journal-title":"Trends Org. Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis","volume":"146","author":"Potente","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2015.06.037_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5482\/ha-1163","article-title":"Angiogenesis in cancer","volume":"32","author":"Prager","year":"2012","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.cbi.2015.06.037_b0030","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2015.06.037_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/156800912798888956","article-title":"The critical role of vascular endothelial growth factor in tumor angiogenesis","volume":"12","author":"Amini","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.cbi.2015.06.037_b0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lfs.2013.05.018","article-title":"Inhibition of metastatic potential of B16F10 melanoma cell line in vivo and in vitro by biflorin","volume":"93","author":"Carvalho","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2015.06.037_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2015.06.037_b0050","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","article-title":"The thalidomide saga","volume":"39","author":"Melchert","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2015.06.037_b0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1248\/cpb.55.223","article-title":"Thalidomide analogs from diamines: synthesis and evaluation as inhibitors of TNF-alpha production","volume":"55","author":"Almeida","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.cbi.2015.06.037_b0060","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.bmcl.2005.08.086","article-title":"Angiogenesis inhibitors derived from thalidomide","volume":"15","author":"Noguchi","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0065","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-010-0619-9","article-title":"Teratogenic effects of thalidomide: molecular mechanisms","volume":"68","author":"Ito","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2015.06.037_b0070","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00044-013-0730-1","article-title":"Phthaloyl amino acids as anti-inflammatory and immunomodulatory prototypes","volume":"23","author":"Leite","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.cbi.2015.06.037_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11899-012-0146-x","article-title":"Lenalidomide alone and in combination for chronic lymphocytic leukemia","volume":"8","author":"Chen","year":"2013","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.cbi.2015.06.037_b0080","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.critrevonc.2013.02.001","article-title":"Pomalidomide: new immunomodulatory agent with potent antiproliferative effects","volume":"88","author":"Richardson","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cbi.2015.06.037_b0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cmdc.200900525","article-title":"Discovery of phthalimides as immunomodulatory and antitumor drug prototypes","volume":"5","author":"Pessoa","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival \u2013 application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2015.06.037_b0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2013.06.009","article-title":"Antiproliferative activity of Rhinella marina and Rhaebo guttatus venom extracts from Southern Amazon","volume":"72","author":"Ferreira","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.cbi.2015.06.037_b0100","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1590\/S0001-37652011005000017","article-title":"Study of the antiproliferative potential of seed extracts from Northeastern Brazilian plants","volume":"83","author":"Ferreira","year":"2011","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.cbi.2015.06.037_b0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1073\/pnas.70.2.369","article-title":"A factor from a transformed cell line that affects cell migration","volume":"70","author":"Burk","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2015.06.037_b0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.cr.7310039","article-title":"Knockdown of CD146 reduces the migration and proliferation of human endothelial cells","volume":"16","author":"Yanyong","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.cbi.2015.06.037_b0115","unstructured":"F.V. Fechine-Jamacaru, In vivo quantification of corneal angiogenesis using digital image processing (Ph.D. Thesis in Surgery), Federal University of Cear\u00e1, Department of Surgery, Fortaleza, Cear\u00e1, Brazil, 2006."},{"key":"10.1016\/j.cbi.2015.06.037_b0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1590\/S0102-86502012000800003","article-title":"Angiogenesis inhibition by green propolis and the angiogenic effect of l-lysine on bladder cancer in rats","volume":"27","author":"Dornelas","year":"2012","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.cbi.2015.06.037_b0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00280-004-0995-7","article-title":"Antiangiogenic and antitumoral properties of polysaccharide isolated from the seaweed Sargassum stenophyllum","volume":"56","author":"Dias","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2015.06.037_b0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/mvre.1994.1003","article-title":"Quantitation of angiogenesis and antiangiogenesis in the chick-embryo chorioallantoic membrane","volume":"47","author":"Nguyen","year":"1994","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.cbi.2015.06.037_b0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jmor.1050880104","article-title":"A series of normal stages in the development of the chick embryo","volume":"88","author":"Hamburger","year":"1951","journal-title":"J. Morphol."},{"key":"10.1016\/j.cbi.2015.06.037_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.taap.2013.01.010","article-title":"Inhibition of DNA topoisomerase I activity and induction of apoptosis by thiazacridine derivatives","volume":"268","author":"Barros","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2015.06.037_b0145","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.tiv.2013.03.010","article-title":"Induction of G2\/M arrest, caspase activation and apoptosis by \u03b1-santonin derivatives in HL-60 cells","volume":"27","author":"Ferreira","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.cbi.2015.06.037_b0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1590\/S0100-40422007000200008","article-title":"Synthesis and characterization of new amino acyl-4-thiazolidones","volume":"30","author":"Leite","year":"2007","journal-title":"Quim. Nova"},{"key":"10.1016\/j.cbi.2015.06.037_b0155","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1016\/j.bmc.2005.05.066","article-title":"Plant-based anticancer molecules: a chemical and biological profile of some important leads","volume":"13","author":"Srivastava","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4065\/75.9.897","article-title":"Thalidomide in the treatment of relapsed multiple myeloma","volume":"75","author":"Rajkumar","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cbi.2015.06.037_b0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ardp.200700217","article-title":"Thalidomide as a multi-template for development of biologically active compounds","volume":"341","author":"Hashimoto","year":"2008","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.cbi.2015.06.037_b0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1590\/S0100-40422004000300017","article-title":"Semicarbazones and thiosemicarbazones: their wide pharmacological profile and clinical applications","volume":"27","author":"Beraldo","year":"2004","journal-title":"Qu\u00edm. Nova"},{"key":"10.1016\/j.cbi.2015.06.037_b0175","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1016\/j.bmc.2008.09.071","article-title":"Design synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice","volume":"16","author":"Zahran","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0180","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/jm0606342","article-title":"Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity","volume":"49","author":"Richardson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0185","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jm900552r","article-title":"Thiosemicarbazones from the old to new: Iron chelators there are more than just ribonucleotide reductase inhibitors","volume":"52","author":"Yu","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0190","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.foodchem.2010.12.035","article-title":"In vivo antitumoural activity and composition of an oil extract of Brazilian pr\u00f3polis","volume":"126","author":"Carvalho","year":"2011","journal-title":"Food Chem."},{"key":"10.1016\/j.cbi.2015.06.037_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0001-37652010000200017","article-title":"In vitro and in vivo antiproliferative activity of Calotropis procera stem extracts","volume":"82","author":"Magalh\u00e3es","year":"2010","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.cbi.2015.06.037_b0200","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3109\/13880209.2012.684691","article-title":"In vitro and in vivo anticancer properties of cucurbitacin isolated from Cayaponia racemosa","volume":"50","author":"Milit\u00e3o","year":"2012","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.cbi.2015.06.037_b0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cellimm.2011.03.018","article-title":"Thalidomide inhibits interferon-\u03b3-mediated nitric oxide production in mouse vascular endothelial cells","volume":"270","author":"Badamtseren","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cbi.2015.06.037_b0210","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0006-2952(98)00046-X","article-title":"Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent","volume":"55","author":"Bauer","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2015.06.037_b0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biopha.2012.08.006","article-title":"Evaluation of the effects of thalidomide-loaded biodegradable devices in solid Ehrlich tumor","volume":"67","author":"Pereira","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2015.06.037_b0220","series-title":"Pathologic Basis of Disease","author":"Kumar","year":"2004"},{"key":"10.1016\/j.cbi.2015.06.037_b0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrc1323","article-title":"The evolution of thalidomide and its IMiD derivatives as anticancer agents","volume":"4","author":"Bartlett","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2015.06.037_b0230","doi-asserted-by":"crossref","DOI":"10.1590\/0001-3765201520130345","article-title":"Cytotoxic and toxicological effects of phthalimide derivatives on tumor and normal murine cells","author":"Ferreira","year":"2015","journal-title":"An. Acad. Bras. Cienc"},{"key":"10.1016\/j.cbi.2015.06.037_b0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2012.07.004","article-title":"The application and biology of immunomodulatory drugs (IMiDs) in cancer","volume":"136","author":"Pan","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2015.06.037_b0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.cbi.2015.06.037_b0245","first-page":"3673","article-title":"Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo","volume":"16","author":"Gutman","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2015.06.037_b0250","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.bjc.6600607","article-title":"Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects","volume":"87","author":"Dredge","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2015.06.037_b0255","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbrc.2010.08.003","article-title":"A novel nucleic acid analogue shows strong angiogenic activity","volume":"399","author":"Tsukamoto","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2015.06.037_b0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tice.2011.03.004","article-title":"Effect of different mitogens and serum concentration on HUVEC morphology and characteristics: implication on use of higher passage cells","volume":"43","author":"Bala","year":"2011","journal-title":"Tissue Cell"},{"key":"10.1016\/j.cbi.2015.06.037_b0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hon.992","article-title":"Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro","volume":"30","author":"Li","year":"2011","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.cbi.2015.06.037_b0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.10681","article-title":"Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice","volume":"102","author":"Bruns","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cbi.2015.06.037_b0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cytogfr.2007.01.008","article-title":"SLAM and CD31: signaling molecules involved in cytokine secretion during the development of innate and adaptive immune responses","volume":"18","author":"Garc\u00eda","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cbi.2015.06.037_b0280","first-page":"25","article-title":"The biology of PECAM-1","volume":"100","author":"Newman","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2015.06.037_b0285","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/01.ATV.0000071347.69358.D9","article-title":"Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology","volume":"23","author":"Newman","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2015.06.037_b0290","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0015-0282(02)03301-0","article-title":"Expression of von Willebrand\u2019s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas","volume":"78","author":"Poncelet","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cbi.2015.06.037_b0295","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1248\/bpb.25.597","article-title":"Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation","volume":"25","author":"Marks","year":"2002","journal-title":"Biol. Pharm. Bull."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715300120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715300120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:38:01Z","timestamp":1757857081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279715300120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":59,"alternative-id":["S0009279715300120"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2015.06.037","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2015.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}